|
Volumn 17, Issue 5 SUPPL. 1, 1995, Pages
|
Therapeutic strategy in Paget's disease of bone
a a |
Author keywords
Activity index; Bisphosphonates; Bone remodeling; Disease extent; Paget's disease; Therapeutic strategy
|
Indexed keywords
ALENDRONIC ACID;
BIOCHEMICAL MARKER;
ETIDRONIC ACID;
PAMIDRONIC ACID;
RISEDRONIC ACID;
TILUDRONIC ACID;
ARTHROPATHY;
BONE MALFORMATION;
BONE MINERALIZATION;
BONE PAIN;
BONE REMODELING;
BONE STRUCTURE;
CENTRAL NERVOUS SYSTEM DISEASE;
CONFERENCE PAPER;
HUMAN;
HYPERTROPHY;
INTRAVENOUS DRUG ADMINISTRATION;
LIFE EXPECTANCY;
MORPHOMETRICS;
ORTHOPEDIC SURGERY;
OSTEOCLAST;
OSTEOLYSIS;
PAGET BONE DISEASE;
RISK;
TREATMENT PLANNING;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ALKALINE PHOSPHATASE;
ANALGESICS, NON-NARCOTIC;
BIOLOGICAL MARKERS;
BONE AND BONES;
CLODRONIC ACID;
DIPHOSPHONATES;
ETIDRONIC ACID;
FEMALE;
FOLLOW-UP STUDIES;
HUMAN;
HYDROXYPROLINE;
INJECTIONS, INTRAVENOUS;
LONGITUDINAL STUDIES;
MALE;
MIDDLE AGE;
OSTEITIS DEFORMANS;
RISK ASSESSMENT;
SKULL;
|
EID: 0028809561
PISSN: 87563282
EISSN: None
Source Type: Journal
DOI: 10.1016/8756-3282(95)00260-2 Document Type: Article |
Times cited : (76)
|
References (11)
|